Status:

COMPLETED

Immune Enhancement for Immunological Non-responders to ART

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

HIV

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

The purpose of this study is to see if taking two nutritional supplements, zinc and SAMe (S-adenosylmethionine), can improve lung health and immune function in persons with HIV. You are being asked to...

Detailed Description

There will be up to eleven study visits and three telephone visits. All study procedures are for research purposes. All study subjects will receive the nutritional supplements zinc and SAMe. During t...

Eligibility Criteria

Inclusion

  • 1\. Subjects living with HIV-1 infection who have been on anti-retroviral therapy (ART) for a minimum of 18 months and:
  • are followed longitudinally for their HIV healthcare in one of the study sites in Atlanta or Seattle
  • meet criteria for immunological non-responsiveness as defined by adherence to ART and cluster of differentiation 4 (CD4) count \<350 despite adequate retroviral suppression.
  • 2\. Ability to give informed consent.

Exclusion

  • Documented history of cirrhosis or a total bilirubin ≥ 2.0 mg/dL.
  • Documentation of left ventricular ejection fraction \< 40% or myocardial infarction within the past 6 months.
  • End-stage renal disease requiring dialysis or a serum creatinine ≥ 2 mg/dL.
  • Spirometry with Forced vital capacity (FVC) or Forced expiratory volume in 1 second (FEV1) \< 70% of predicted value.
  • Diabetes
  • Known or possible pregnancy or attempting to become pregnant.
  • BMI \< 17
  • Age \< 21
  • Parkinson's disease: these are all b/c the SAMe risks sections states that these pts will not qualify
  • Bipolar disorder
  • Bleeding disorders such as thrombocytopenia or significant gastrointestinal bleeding within the past year

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 15 2018

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01806870

Start Date

March 1 2013

End Date

December 15 2018

Last Update

July 18 2019

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Grady Hospital- Ponce De Leon Clinic

Atlanta, Georgia, United States, 30308

2

Atlanta VA Medical Center

Decatur, Georgia, United States, 30033